UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Quest Diagnostics
DGX
$27.6B
| $188M | 0.02% |
888,906
+186,569
| +27% | +$36.6M |
2014 Q4
46 quarters
|
|
702
VSE Corp
VSEC
$4.53B
| $188M | 0.02% |
824,499
-139,998
| -15% | -$26.9M |
2016 Q3
39 quarters
|
|
703
Dimensional International Core Equity Market ETF
DFAI
$18.2B
| $188M | 0.02% |
4,567,118
+372,171
| +9% | +$15.3M |
2021 Q2
20 quarters
|
|
704
iShares Preferred and Income Securities ETF
PFF
$11.6B
| $188M | 0.02% |
6,178,759
+83,670
| +1% | +$2.61M |
2014 Q4
46 quarters
|
|
705
CALL
TotalEnergies
TTE
$204B
| $188M | 0.02% |
2,420,371
-602,932
| -20% | -$53.3M |
2025 Q4
2 quarters
|
|
706
Cencora
COR
$63.8B
| $188M | 0.02% |
663,848
-109,159
| -14% | -$31.5M |
2014 Q4
46 quarters
|
|
707
IDEX
IEX
$17.4B
| $187M | 0.02% |
825,098
+183,398
| +29% | +$38.8M |
2014 Q4
46 quarters
|
|
708
Zebra Technologies
ZBRA
$17.2B
| $187M | 0.02% |
709,992
+120,103
| +20% | +$28.2M |
2014 Q4
46 quarters
|
|
709
Schwab U.S Small- Cap ETF
SCHA
$22.1B
| $187M | 0.02% |
5,171,149
+41,425
| +0.8% | +$1.37M |
2014 Q4
46 quarters
|
|
710
Semtech
SMTC
$11.5B
| $187M | 0.02% |
1,154,041
+262,380
| +29% | +$34.3M |
2014 Q4
46 quarters
|
|
711
CALL
AST SpaceMobile
ASTS
$11.1B
| $187M | 0.02% |
2,100,645
-1,000,980
| -32% | -$87.3M |
2025 Q1
5 quarters
|
|
712
StandardAero Inc
SARO
$8.28B
| $186M | 0.02% |
6,235,322
+2,762,384
| +80% | +$72.6M |
2024 Q4
6 quarters
|
|
713
Regeneron Pharmaceuticals
REGN
$100B
| $186M | 0.02% |
298,234
-1,745
| -0.6% | -$1.19M |
2014 Q4
46 quarters
|
|
714
Occidental Petroleum
OXY
$60.7B
| $186M | 0.02% |
3,825,633
+776,447
| +25% | +$44.1M |
2014 Q4
46 quarters
|
|
715
Novartis
NVS
$305B
| $186M | 0.02% |
1,184,422
-608,731
| -34% | -$91.3M |
2014 Q4
46 quarters
|
|
716
iShares MSCI ACWI ETF
ACWI
$32.3B
| $185M | 0.02% |
1,178,489
+29,030
| +3% | +$4.44M |
2014 Q4
46 quarters
|
|
717
Fair Isaac
FICO
$15.5B
| $185M | 0.02% |
154,732
+75,922
| +96% | +$85M |
2014 Q4
46 quarters
|
|
718
Somnigroup International
SGI
$15.2B
| $185M | 0.02% |
2,355,412
+855,812
| +57% | +$62.7M |
2014 Q4
46 quarters
|
|
719
Tyler Technologies
TYL
$16.1B
| $184M | 0.02% |
629,974
+386,275
| +159% | +$122M |
2014 Q4
46 quarters
|
|
720
Becton Dickinson
BDX
$54.3B
| $184M | 0.02% |
1,213,811
-208,492
| -15% | -$31.2M |
2014 Q4
46 quarters
|
|
721
Viking Holdings
VIK
$38.9B
| $182M | 0.02% |
1,743,298
-2,049,026
| -54% | -$177M |
2024 Q2
8 quarters
|
|
722
Jazz Pharmaceuticals
JAZZ
$14B
| $182M | 0.02% |
756,865
+399,662
| +112% | +$87.6M |
2014 Q4
46 quarters
|
|
723
Halliburton
HAL
$28.9B
| $182M | 0.02% |
5,367,774
+1,292,571
| +32% | +$50.5M |
2014 Q4
46 quarters
|
|
724
CALL
Ormat Technologies
ORA
$5.61B
| $182M | 0.02% |
1,672,026
| – | – |
2024 Q1
9 quarters
|
|
725
Baker Hughes
BKR
$53.5B
| $181M | 0.02% |
3,268,362
-998,942
| -23% | -$63.2M |
2017 Q3
35 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.